Global Bioinformatics Platforms Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Bioinformatics Platforms Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Bioinformatics platform combines statistical analysis modules to enable faster and easier analysis and integration and visualization of different types of big data generated through analysis of microbial genomes. Various bioinformatics tools for comparative analyses on gene level have been developed such as IMG/M, MicrobesOnline, MBGD, Roary, and EDGAR.
Bioinformatics Platforms report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bioinformatics Platforms market is projected to reach US$ 942.5 million in 2033, increasing from US$ 632 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2033. Demand from Drug Development and Molecular Genomics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bioinformatics Platforms industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Bioinformatics Platforms key companies include Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, GenoLogics Life Sciences and Illumina, etc. Affymetrix, Dassault Systemes, Agilent Technologies are top 3 players and held % share in total in 2022.
Bioinformatics Platforms can be divided into Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms and Structural & Functional Analysis Platforms, etc. Sequence Analysis Platforms is the mainstream product in the market, accounting for % share globally in 2022.
Bioinformatics Platforms is widely used in various fields, such as Drug Development, Molecular Genomics, Personalized Medicine and Gene Therapy, etc. Drug Development provides greatest supports to the Bioinformatics Platforms industry development. In 2022, global % share of Bioinformatics Platforms went into Drug Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Bioinformatics Platforms market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Affymetrix
Dassault Systemes
Agilent Technologies
QIAGEN
ID Business Solutions
GenoLogics Life Sciences
Illumina
Segment by Type
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Structural & Functional Analysis Platforms
Others
Drug Development
Molecular Genomics
Personalized Medicine
Gene Therapy
Protein Function Analysis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bioinformatics Platforms market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bioinformatics Platforms introduction, etc. Bioinformatics Platforms Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Bioinformatics Platforms market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Bioinformatics Platforms report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bioinformatics Platforms market is projected to reach US$ 942.5 million in 2033, increasing from US$ 632 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2033. Demand from Drug Development and Molecular Genomics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bioinformatics Platforms industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Bioinformatics Platforms key companies include Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, GenoLogics Life Sciences and Illumina, etc. Affymetrix, Dassault Systemes, Agilent Technologies are top 3 players and held % share in total in 2022.
Bioinformatics Platforms can be divided into Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms and Structural & Functional Analysis Platforms, etc. Sequence Analysis Platforms is the mainstream product in the market, accounting for % share globally in 2022.
Bioinformatics Platforms is widely used in various fields, such as Drug Development, Molecular Genomics, Personalized Medicine and Gene Therapy, etc. Drug Development provides greatest supports to the Bioinformatics Platforms industry development. In 2022, global % share of Bioinformatics Platforms went into Drug Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Bioinformatics Platforms market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Affymetrix
Dassault Systemes
Agilent Technologies
QIAGEN
ID Business Solutions
GenoLogics Life Sciences
Illumina
Segment by Type
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Structural & Functional Analysis Platforms
Others
Segment by Application
Drug Development
Molecular Genomics
Personalized Medicine
Gene Therapy
Protein Function Analysis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bioinformatics Platforms market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bioinformatics Platforms introduction, etc. Bioinformatics Platforms Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Bioinformatics Platforms market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.